149 related articles for article (PubMed ID: 21426924)
1. Genetic correction of X-linked chronic granulomatous disease with novel foamy virus vectors.
Chatziandreou I; Siapati EK; Vassilopoulos G
Exp Hematol; 2011 Jun; 39(6):643-52. PubMed ID: 21426924
[TBL] [Abstract][Full Text] [Related]
2. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
Nunoi H; Ishibashi F
Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
[TBL] [Abstract][Full Text] [Related]
3. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
Nunoi H; Ishibashi F
Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
[TBL] [Abstract][Full Text] [Related]
4. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
[TBL] [Abstract][Full Text] [Related]
5. Progress in gene therapy for chronic granulomatous disease.
Malech HL
J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
[TBL] [Abstract][Full Text] [Related]
6. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
[TBL] [Abstract][Full Text] [Related]
8. Chronic granulomatous disease: towards gene therapy.
Thrasher A; Segal A; Casimir C
Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
[TBL] [Abstract][Full Text] [Related]
9. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene.
von Goessel H; Hossle JP; Seger R; Gungor T
Exp Hematol; 2006 Apr; 34(4):528-35. PubMed ID: 16569599
[TBL] [Abstract][Full Text] [Related]
11. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
[TBL] [Abstract][Full Text] [Related]
12. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
[TBL] [Abstract][Full Text] [Related]
13. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
[TBL] [Abstract][Full Text] [Related]
15. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
[TBL] [Abstract][Full Text] [Related]
16. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22(0)) leading to the activation of a cryptic splice site in intron 4.
Stasia MJ; Bordigoni P; Martel C; Morel F
Hum Genet; 2002 May; 110(5):444-50. PubMed ID: 12073015
[TBL] [Abstract][Full Text] [Related]
17. Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBB.
Stasia MJ; Brion JP; Boutonnat J; Morel F
J Infect Dis; 2003 Nov; 188(10):1593-604. PubMed ID: 14624387
[TBL] [Abstract][Full Text] [Related]
18. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody 7D5 recognizes the R147 epitope on the gp91
Kawai C; Yamauchi A; Kuribayashi F
Microbiol Immunol; 2018 Apr; 62(4):269-280. PubMed ID: 29573449
[TBL] [Abstract][Full Text] [Related]
20. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
